Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03935958Not ApplicableActive Not Recruiting

Curcumin in Kidney Transplant Recipients

Role: collaborator

NCT01001637Not ApplicableTerminated

Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease

Role: collaborator

NCT03289507Not ApplicableCompleted

Longvida Curcumin Human Pharmacokinetics Study

Role: collaborator

NCT04596722Not ApplicableCompleted

Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties

Role: collaborator

NCT04586816Not ApplicableCompleted

Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging

Role: collaborator

All 5 trials loaded